‘Always Finish Your Antibiotics’ Is Not Always Best Practice. Surprised? You’re Not Alone

For decades, patients have been advised to always complete their full course of antibiotics, a recommendation dating back to penicillin’s discovery in the 1940s. However, emerging scientific evidence challenges this long-standing medical guidance. Researchers from the University of Utah and other public health experts report that shorter antibiotic courses may be equally effective and safe for treating certain common bacterial infections, including some cases of pneumonia.

Recent analysis of over 120 randomized controlled trials demonstrates that abbreviated treatment durations produce comparable outcomes to longer courses without increasing antibiotic resistance risk. Some experts argue that unnecessarily prolonged antibiotic exposure could actually contribute to resistance problems rather than prevent them. Despite this growing body of evidence, patients continue preferring longer courses, largely due to decades of messaging emphasizing treatment completion.

A survey of nearly 1,500 Americans revealed most respondents favored seven-or-more-day courses over three-to-five-day alternatives. Importantly, while the majority had never received instructions to discontinue antibiotics early, most expressed comfort with such guidance from their healthcare providers. The disconnect between current medical understanding and public perception underscores the need for improved patient-clinician communication regarding treatment duration.

Experts emphasize that patients should follow their doctor’s prescribed duration rather than making independent decisions. Certain serious infections, including tuberculosis and specific staph infections, genuinely require extended treatment. Researchers recommend healthcare providers frame evolving antibiotic guidance as normal scientific progress to build patient understanding and trust.

Originally reported by Sciencealert →